[go: up one dir, main page]

SK284476B6 - Tuhé, rýchlo sa rozpadajúce formulácie cetirizínu - Google Patents

Tuhé, rýchlo sa rozpadajúce formulácie cetirizínu Download PDF

Info

Publication number
SK284476B6
SK284476B6 SK1431-2000A SK14312000A SK284476B6 SK 284476 B6 SK284476 B6 SK 284476B6 SK 14312000 A SK14312000 A SK 14312000A SK 284476 B6 SK284476 B6 SK 284476B6
Authority
SK
Slovakia
Prior art keywords
acid
effervescent
formulations according
effervescent formulations
cetirizine
Prior art date
Application number
SK1431-2000A
Other languages
English (en)
Slovak (sk)
Other versions
SK14312000A3 (sk
Inventor
Wolfram Tritthart
Mario Andr Piskernig
Original Assignee
Viatris Gmbh & Co. Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Viatris Gmbh & Co. Kg filed Critical Viatris Gmbh & Co. Kg
Publication of SK14312000A3 publication Critical patent/SK14312000A3/sk
Publication of SK284476B6 publication Critical patent/SK284476B6/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
SK1431-2000A 1998-03-31 1999-03-20 Tuhé, rýchlo sa rozpadajúce formulácie cetirizínu SK284476B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19814256A DE19814256A1 (de) 1998-03-31 1998-03-31 Feste, schnellzerfallende Cetirizin-Formulierungen
PCT/DE1999/000799 WO1999049843A1 (de) 1998-03-31 1999-03-20 Feste, schnellzerfallende cetirizin-formulierungen

Publications (2)

Publication Number Publication Date
SK14312000A3 SK14312000A3 (sk) 2001-07-10
SK284476B6 true SK284476B6 (sk) 2005-04-01

Family

ID=7863014

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1431-2000A SK284476B6 (sk) 1998-03-31 1999-03-20 Tuhé, rýchlo sa rozpadajúce formulácie cetirizínu

Country Status (30)

Country Link
US (1) US6245353B1 (es)
EP (1) EP1067904B1 (es)
JP (1) JP2002509873A (es)
KR (1) KR100653568B1 (es)
CN (1) CN1136838C (es)
AR (1) AR018828A1 (es)
AT (1) ATE209899T1 (es)
AU (1) AU750140B2 (es)
BG (1) BG64741B1 (es)
BR (1) BR9909233A (es)
CA (1) CA2326809C (es)
CY (1) CY1107331T1 (es)
CZ (1) CZ300704B6 (es)
DE (2) DE19814256A1 (es)
DK (1) DK1067904T3 (es)
ES (1) ES2168013T3 (es)
HU (1) HU227477B1 (es)
IL (1) IL138606A (es)
NO (1) NO329071B1 (es)
NZ (1) NZ506988A (es)
PL (1) PL191266B1 (es)
PT (1) PT1067904E (es)
RU (1) RU2216318C2 (es)
SI (1) SI1067904T1 (es)
SK (1) SK284476B6 (es)
TR (1) TR200002809T2 (es)
TW (1) TWI233808B (es)
UA (1) UA57615C2 (es)
WO (1) WO1999049843A1 (es)
ZA (1) ZA200005134B (es)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2415643C (en) 2000-07-17 2010-11-16 Yamanouchi Pharmaceutical Co., Ltd. Pharmaceutical composition for oral use with improved absorption
JP4724367B2 (ja) * 2002-01-15 2011-07-13 ユセベ ファルシム ソシエテ アノニム 処方
JP2005526104A (ja) * 2002-04-04 2005-09-02 ファイザー・プロダクツ・インク 味の良い咀嚼可能な錠剤
US20080287456A1 (en) * 2004-05-28 2008-11-20 Imaginot Pty Ltd Oral Therapeutic Compound Delivery System
US8216610B2 (en) 2004-05-28 2012-07-10 Imaginot Pty Ltd. Oral paracetamol formulations
US8758816B2 (en) * 2004-11-24 2014-06-24 Meda Pharmaceuticals Inc. Compositions comprising azelastine and methods of use thereof
US20070020330A1 (en) 2004-11-24 2007-01-25 Medpointe Healthcare Inc. Compositions comprising azelastine and methods of use thereof
PL2522365T3 (pl) 2004-11-24 2017-05-31 Meda Pharmaceuticals Inc. Kompozycje zawierające azelastynę i sposoby ich zastosowania
US20060198885A1 (en) * 2005-02-22 2006-09-07 Sun Pharmaceutical Industries Ltd. Oral pharmaceutical composition
US9757455B2 (en) 2005-11-28 2017-09-12 Johnson & Johnson Consumer Inc. Oral therapeutic compound delivery system
AU2009288006B2 (en) * 2008-09-05 2014-07-17 Mcneil-Ppc, Inc. Method for making cetirizine tablets
EP2405747A4 (en) * 2009-03-13 2013-01-16 Nucitec Sa De Cv COMPOSITIONS AND METHODS FOR TREATMENT AND PREVENTION OF CARDIOVASCULAR DISEASES
EP2571484A2 (en) * 2010-05-18 2013-03-27 Mahmut Bilgic Effervescent formulations
US20140371174A1 (en) 2013-06-12 2014-12-18 The Procter & Gamble Company Effervescent Dosage Form
BR112014030680B1 (pt) 2012-06-12 2022-08-30 The Procter & Gamble Company Forma de dosagem mastigável efervescente
JP5945191B2 (ja) * 2012-08-09 2016-07-05 株式会社ファンケル 口腔内速崩錠
JP6092672B2 (ja) * 2013-03-21 2017-03-08 株式会社ファンケル 口腔内速崩壊性錠剤
KR101591319B1 (ko) * 2013-12-03 2016-02-18 에프엔바이오 주식회사 홍삼 발포정의 제조방법
TW201605447A (zh) * 2014-06-20 2016-02-16 美林塔治療學有限公司 處理感染的方法
TWI705814B (zh) * 2014-06-20 2020-10-01 美商梅琳塔有限責任公司 醫藥組成物及其用途
EP3061501A1 (en) 2015-02-27 2016-08-31 Rottapharm Ltd. Composition for the treatment of acne
EP3117825A1 (en) 2015-07-16 2017-01-18 Rottapharm S.p.A. Oral formulation comprising berberine and morus alba extract
CN106109422A (zh) * 2016-07-28 2016-11-16 北京万全德众医药生物技术有限公司 盐酸左西替利嗪泡腾颗粒及其制备方法
US10624921B2 (en) 2016-11-15 2020-04-21 Berkeley Nox Limited Dietary supplements
JP2018108950A (ja) * 2016-12-28 2018-07-12 沢井製薬株式会社 レボセチリジン塩酸塩含有口腔内崩壊錠
WO2019099003A2 (en) * 2017-11-15 2019-05-23 Berkeley Nox Limited Novel dietary supplements
PT3799864T (pt) 2019-10-02 2023-05-25 Intas Pharmaceuticals Ltd Composições farmacêuticas sólidas efervescentes essencialmente isentas de sódio
KR20220137065A (ko) * 2020-02-03 2022-10-11 존슨 앤드 존슨 컨수머 인코포레이티드 세티리진을 포함하는 단일층 츄어블 정제
CN120437087A (zh) 2024-02-01 2025-08-08 科赴品牌有限责任公司 一种口腔溶解膜制剂、其用途及其制备方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO155805C (no) * 1981-02-06 1987-06-10 Ucb Sa Analogifremgangsmaate for fremstilling av terapeutisk virksomme 2-(4-(difenylmethyl)-1-piperazinyl)-eddiksyrer og deres amider og ikke-toksiske salter.
US4678661A (en) * 1983-09-28 1987-07-07 Gerhard Gergely Effervescent composition and method of making same
US4792448A (en) * 1987-06-11 1988-12-20 Pfizer Inc. Generic zero order controlled drug delivery system
IL91398A (en) * 1988-08-30 1994-05-30 Pfizer Pharmaceutical delivery device comprising active substance surrounded by asymmetric membrane
US5178878A (en) 1989-10-02 1993-01-12 Cima Labs, Inc. Effervescent dosage form with microparticles
DE69107461T2 (de) * 1990-08-07 1995-06-22 Pfizer Verwendung von interfacial polymerisierten membranen in abgabevorrichtungen.
DK0584108T3 (da) * 1991-05-13 2000-10-09 Boots Co Plc Farmaceutisk præparat omfattende ibuprofensalt
GB9119052D0 (en) * 1991-09-06 1991-10-23 Boots Co Plc Pharmaceutical compositions
MX9300110A (es) * 1992-01-13 1994-07-29 Gerhard Gergely Preparacion farmaceutica en la forma de una tableta de efervescencia o de desintegracion o de un granulado de tipo instanteneo y procedimiento para su preparacion.
NZ256346A (en) * 1992-10-09 1997-04-24 Procter & Gamble Medicaments containing 3-l-menthoxypropane-1,2-diol for treating cold symptoms
GB9224021D0 (en) * 1992-11-16 1993-01-06 Boots Co Plc Effervescent compositions
FR2698788B1 (fr) * 1992-12-09 1995-03-03 Union Pharma Scient Appl Composition pharmaceutique effervescente contenant de l'ibuprofène et son procédé de préparation.
TW401300B (en) * 1992-12-25 2000-08-11 Senju Pharma Co Antiallergic composition for ophthalmic or nasal use
ATE140621T1 (de) * 1993-04-15 1996-08-15 Gergely Gerhard Brausesystem mit einem alkali- und/oder metallempfindlichen, pharmazeutischen wirkstoff, und verfahren zur herstellung
FI955144A7 (fi) * 1993-04-30 1995-10-31 Procter & Gamble Päällystetyt farmaseuttiset koostumukset
US5458879A (en) * 1994-03-03 1995-10-17 The Procter & Gamble Company Oral vehicle compositions

Also Published As

Publication number Publication date
AU750140B2 (en) 2002-07-11
CN1295464A (zh) 2001-05-16
HUP0102676A3 (en) 2002-12-28
BR9909233A (pt) 2000-11-28
BG64741B1 (bg) 2006-02-28
DE59900501D1 (de) 2002-01-17
ES2168013T3 (es) 2002-05-16
CZ300704B6 (cs) 2009-07-22
CA2326809A1 (en) 1999-10-07
ZA200005134B (en) 2000-12-21
HK1036217A1 (en) 2001-12-28
JP2002509873A (ja) 2002-04-02
ATE209899T1 (de) 2001-12-15
HUP0102676A2 (hu) 2001-11-28
TWI233808B (en) 2005-06-11
TR200002809T2 (tr) 2000-12-21
BG104843A (en) 2001-07-31
KR20010034718A (ko) 2001-04-25
PL191266B1 (pl) 2006-04-28
DK1067904T3 (da) 2002-04-02
NZ506988A (en) 2002-05-31
RU2216318C2 (ru) 2003-11-20
EP1067904A1 (de) 2001-01-17
CY1107331T1 (el) 2012-12-19
CA2326809C (en) 2008-11-18
EP1067904B1 (de) 2001-12-05
US6245353B1 (en) 2001-06-12
CZ20003481A3 (en) 2001-05-16
CN1136838C (zh) 2004-02-04
SI1067904T1 (en) 2002-04-30
HU227477B1 (en) 2011-07-28
AR018828A1 (es) 2001-12-12
AU3925399A (en) 1999-10-18
SK14312000A3 (sk) 2001-07-10
IL138606A (en) 2005-07-25
WO1999049843A1 (de) 1999-10-07
NO329071B1 (no) 2010-08-16
KR100653568B1 (ko) 2006-12-05
DE19814256A1 (de) 1999-10-07
NO20004722L (no) 2000-09-21
PT1067904E (pt) 2002-05-31
PL343199A1 (en) 2001-07-30
UA57615C2 (uk) 2003-06-16
IL138606A0 (en) 2001-10-31
NO20004722D0 (no) 2000-09-21

Similar Documents

Publication Publication Date Title
SK284476B6 (sk) Tuhé, rýchlo sa rozpadajúce formulácie cetirizínu
KR101020809B1 (ko) 펙소페나딘을 함유하는 구강 분산성 정제
ES2462536T3 (es) Comprimido orodispersable multicapa
EP1370247B1 (en) Taste masked pharmaceutical compositions
US8048449B2 (en) Mouth dissolving pharmaceutical composition and process for preparing the same
US6242002B1 (en) Effervescent formulations
US6669957B1 (en) Galenic formulations fast disintegrating in the mouth and method for preparing same
RU2671491C2 (ru) Комплексная гранулированная композиция, обладающая улучшенной стабильностью, включающая левоцетиризин и монтелукаст
US20050112196A1 (en) Rapidly disintegrating formulation
US20060062844A1 (en) Taste-masking coated particles, process for the preparation thereof and orodispersible tablets containing said coated particles
US20110046115A1 (en) Mirtazapine Solid Dosage Forms
KR20100086140A (ko) 몬테루카스트를 활성성분으로 함유하는 구강 내 속붕해정 조성물 및 그 제조방법
KR100604034B1 (ko) 암로디핀 유리염기를 함유한 구강 속붕해정 및 그의 조성물
HK1046641A1 (en) Orally disintegrating composition comprising mirtazapine
MXPA00009349A (es) Formulaciones fijas rapidas dispersantes de cetirizina
HK1036217B (en) Solid, quick dissolving cetirizine formulations

Legal Events

Date Code Title Description
MM4A Patent lapsed due to non-payment of maintenance fees

Effective date: 20170320